Clinical Trials
2 trialsNCT02403310 2022-10-03
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT05456048 2022-07-13
Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML
Nanfang Hospital, Southern Medical University
Completed